CORT FY 2023 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$482M+20.0% YoY

Gross Profit

$476M98.7% margin

Operating Income

$107M22.2% margin

Net Income

$106M22.0% margin

EPS (Diluted)

$0.94

Cash Flow

Operating Cash Flow

$127M

Free Cash Flow

$127M

Stock-Based Comp.

$49M

Balance Sheet

Total Assets

$622M

Total Liabilities

$115M

Stockholders' Equity

$507M

Cash & Equivalents

$136M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$482M	$402M	+20.0%
Gross Profit	$476M	$396M	+20.0%
Operating Income	$107M	$113M	-4.8%
Net Income	$106M	$101M	+4.7%